Roseburia intestinalis Supplementation Could Reverse the Learning and Memory Impairment and m6A Methylation Modification Decrease Caused by 27-Hydroxycholesterol in Mice

Xuejing Sun,Cui Zhou,Mengwei Ju,Wenjing Feng,Zhiting Guo,Chengyan Qi,Kexin Yang,Rong Xiao

DOI: https://doi.org/10.3390/nu16091288

IF: 5.9

2024-04-27

Nutrients

Abstract:The abnormality in N6-methyladenosine (m6A) methylation is involved in the course of Alzheimer's disease (AD), while the intervention of 27-Hydroxycholesterol (27-OHC) can affect the m6A methylation modification in the brain cortex. Disordered gut microbiota is a key link in 27-OHC leading to cognitive impairment, and further studies have found that the abundance of Roseburia intestinalis in the gut is significantly reduced under the intervention of 27-OHC. This study aims to investigate the association of 27-OHC, Roseburia intestinalis in the gut, and brain m6A modification in the learning and memory ability injury. In this study, 9-month-old male C57BL/6J mice were treated with antibiotic cocktails for 6 weeks to sweep the intestinal flora, followed by 27-OHC or normal saline subcutaneous injection, and then Roseburia intestinalis or normal saline gavage were applied to the mouse. The 27-OHC level in the brain, the gut barrier function, the m6A modification in the brain, and the memory ability were measured. From the results, we observed that 27-OHC impairs the gut barrier function, causing a disturbance in the expression of m6A methylation-related enzymes and reducing the m6A methylation modification level in the brain cortex, and finally leads to learning and memory impairment. However, Roseburia intestinalis supplementation could reverse the negative effects mentioned above. This study suggests that 27-OHC-induced learning and memory impairment might be linked to brain m6A methylation modification disturbance, while Roseburia intestinalis, as a probiotic with great potential, could reverse the damage caused by 27-OHC. This research could help reveal the mechanism of 27-OHC-induced neural damage and provide important scientific evidence for the future use of Roseburia intestinalis in neuroprotection.

nutrition & dietetics

What problem does this paper attempt to address?

### The Problem the Paper Attempts to Solve

This paper aims to explore the impact of 27-hydroxycholesterol (27-OHC) on learning and memory impairment in mice and investigate whether supplementation with Roseburia intestinalis can reverse these impairments.

Specifically:
1. **Impact of 27-OHC**: 27-OHC can disrupt gut barrier function, lead to abnormal changes in the expression of enzymes related to m6A methylation, and reduce the level of m6A methylation modification in the cerebral cortex, ultimately resulting in impaired learning and memory abilities.
2. **Role of Roseburia intestinalis**: Supplementation with Roseburia intestinalis can reverse the negative effects caused by 27-OHC.
3. **Mechanism Exploration**: The study also attempts to reveal the mechanisms by which 27-OHC causes neural damage and provide important scientific evidence for future neuroprotection using Roseburia intestinalis.

Through these studies, the authors hope to further elucidate the role of 27-OHC in the pathogenesis of Alzheimer's disease (AD) and explore potential therapeutic strategies.